This activity is supported by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.
This activity is supported by educational grants from Amgen; and Ferring Pharmaceuticals, Inc.
NPs and PAs practicing in gastroenterology
Integrate clinical evidence, recent real-world data, current guidance, and patient preferences into individualized treatment plans for patients with IBD
Incorporate evidence-based strategies for IBD treatment de-escalation that may include dose reduction or drug discontinuation once sustained remission has been achieved
Devise a plan for long-term management of IBD that includes treatment of extraintestinal manifestations and treatment AEs
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Afzali: consultant/advisor/speaker: AbbVie, DiaSorin, Eli Lilly, Gilead, Janssen, Pfizer, Takeda, TLL Pharmaceuticals.
Dr Bernasko: consultant/advisor/speaker: AbbVie, Bristol-Myers Squibb, Eli Lilly, Gilead, Pfizer.
Mr Davis has no relevant financial relationships to disclose.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose, except Dr Bernasko as noted above.
Participants wishing to earn CE/CME credit must:
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of 100%.
The estimated time to complete this activity is 0.25 hours.
Release date: May 16, 2022
Expiration date: May 15, 2023
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
NP Course Advisor: Nana Bernasko, DNP, CRNP, WHNP-BC, Penn State University Medical Center, Hershey, Pennsylvania
Nursing contact hours: 0.25, which includes 0.25 hours of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until May 15, 2023. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Richard H. Davis, PA-C, University of Florida College of Medicine, Gainesville, Florida
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credits for learning and change.
This program has been made available online.